State Street Corp Myriad Genetics Inc Transaction History

State Street Corp

$2.36 Trillion
Q1 2025

A detailed history of State Street Corp transactions in Myriad Genetics Inc stock. As of the latest transaction made, State Street Corp holds 5,268,790 shares of MYGN stock, worth $23.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,268,790

Previous 5,525,705 4.65%

Holding current value

$23.4 Million

Previous $75.8 Million 38.31%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$8.87 - $14.98 $2.28 Million - $3.85 Million	-256,915 Reduced 4.65%	5,268,790 $46.7 Million
Q4 2024 Feb 14, 2025	BUY	$13.17 - $27.03 $10.8 Million - $22.2 Million	822,263 Added 17.48%	5,525,705 $75.8 Million
Q3 2024 Nov 14, 2024	BUY	$23.97 - $28.6 $8.62 Million - $10.3 Million	359,685 Added 8.28%	4,703,442 $129 Million
Q2 2024 Aug 14, 2024	SELL	$17.98 - $25.47 $19.1 Million - $27 Million	-1,059,928 Reduced 19.61%	4,343,757 $106 Million
Q1 2024 May 15, 2024	BUY	$17.59 - $23.59 $12.4 Million - $16.6 Million	703,054 Added 14.96%	5,403,685 $115 Million
Q4 2023 Feb 14, 2024	BUY	$13.91 - $21.32 $246,916 - $378,451	17,751 Added 0.38%	4,700,631 $90 Million
Q3 2023 Nov 14, 2023	SELL	$15.99 - $23.22 $641,326 - $931,307	-40,108 Reduced 0.85%	4,682,880 $75.1 Million
Q2 2023 Aug 14, 2023	BUY	$17.56 - $23.76 $2.11 Million - $2.85 Million	120,069 Added 2.61%	4,722,988 $109 Million
Q1 2023 May 15, 2023	SELL	$15.26 - $23.75 $6.37 Million - $9.92 Million	-417,504 Reduced 8.32%	4,602,919 $107 Million
Q4 2022 Feb 14, 2023	BUY	$14.51 - $20.99 $5.27 Million - $7.62 Million	363,160 Added 7.8%	5,020,423 $72.8 Million
Q3 2022 Nov 15, 2022	SELL	$18.21 - $27.88 $2.67 Million - $4.1 Million	-146,894 Reduced 3.06%	4,657,263 $88.9 Million
Q2 2022 Aug 15, 2022	BUY	$16.45 - $25.88 $10 Million - $15.7 Million	607,932 Added 14.49%	4,804,157 $87.3 Million
Q1 2022 May 16, 2022	SELL	$22.67 - $28.01 $4.86 Million - $6 Million	-214,178 Reduced 4.86%	4,196,225 $106 Million
Q4 2021 Feb 14, 2022	BUY	$24.13 - $32.63 $2.79 Million - $3.77 Million	115,570 Added 2.69%	4,410,403 $122 Million
Q3 2021 Nov 15, 2021	BUY	$29.97 - $36.66 $6.16 Million - $7.53 Million	205,528 Added 5.03%	4,294,833 $139 Million
Q2 2021 Aug 16, 2021	BUY	$25.39 - $32.61 $1.39 Million - $1.78 Million	54,648 Added 1.35%	4,089,305 $125 Million
Q1 2021 May 17, 2021	BUY	$19.92 - $31.6 $6.36 Million - $10.1 Million	319,127 Added 8.59%	4,034,657 $123 Million
Q4 2020 Feb 16, 2021	SELL	$12.16 - $19.77 $7.57 Million - $12.3 Million	-622,352 Reduced 14.35%	3,715,530 $73.5 Million
Q3 2020 Nov 10, 2020	SELL	$11.25 - $14.75 $11.7 Million - $15.4 Million	-1,042,716 Reduced 19.38%	4,337,882 $56.6 Million
Q2 2020 Aug 14, 2020	BUY	$10.69 - $16.49 $13.7 Million - $21.2 Million	1,284,595 Added 31.36%	5,380,598 $61 Million
Q1 2020 May 11, 2020	BUY	$9.78 - $29.53 $40.1 Million - $121 Million	4,096,003 New	4,096,003 $58.6 Million

Others Institutions Holding MYGN

# of Institutions

240

Shares Held

95.7M

Call Options Held

95.4K

Put Options Held

18.2K

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $359M
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Myriad Genetics Inc Transaction History